ANDREW LEE to Treatment Outcome
This is a "connection" page, showing publications ANDREW LEE has written about Treatment Outcome.
Connection Strength
0.239
-
Ocular Myasthenia Gravis 32 years From Remission to Relapse. J Neuroophthalmol. 2023 06 01; 43(2):e45-e46.
Score: 0.062
-
The Cost-Effectiveness of Tocilizumab (Actemra) Therapy in Giant Cell Arteritis. J Neuroophthalmol. 2021 Sep 01; 41(3):342-350.
Score: 0.062
-
Transconjunctival versus Transcutaneous Injection of Botulinum Toxin into the Lacrimal Gland to Reduce Lacrimal Production: A Randomized Controlled Trial. Toxins (Basel). 2021 01 21; 13(2).
Score: 0.059
-
Should steroids be offered to patients with nonarteritic anterior ischemic optic neuropathy? J Neuroophthalmol. 2010 Jun; 30(2):193-8.
Score: 0.028
-
Point Counter-Point: Thymectomy in Ocular Myasthenia Gravis. J Neuroophthalmol. 2022 12 01; 42(4):541-546.
Score: 0.017
-
Isolated, Transient, Pneumocephalus-Induced Oculomotor Neuropathy After Microvascular Decompression of the Trigeminal Nerve. World Neurosurg. 2016 Apr; 88:690.e17-690.e22.
Score: 0.010